PRESS RELEASE published on 08/08/2024 at 10:00, 1 year 10 months ago SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers SphingoTec secures €5M Series C funding led by Think.Health Ventures to drive global expansion and commercialize innovative biomarkers for critical care, aiming for improved patient outcomes Funding Biomarkers SphingoTec Critical Care Series C
BRIEF published on 06/18/2024 at 10:05, 1 year 11 months ago SphingoTec Introduces PenKid at AKI & CRRT Course in Vicenza SphingoTec Biomarker AKI Kidney Function PenKid
BRIEF published on 06/18/2024 at 10:05, 1 year 11 months ago SphingoTec présente PenKid au cours AKI & CRRT à Vicence SphingoTec Biomarqueur AKI Fonction Rénale StyloKid
PRESS RELEASE published on 06/18/2024 at 10:00, 1 year 11 months ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 2 years 2 months ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 2 years 2 months ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 2 years 2 months ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 2 years 8 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 2 years 9 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 2 years 9 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
Published on 06/17/2026 at 16:55, 13 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 23 minutes ago Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 2 hours 38 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 3 hours 8 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 15:54, 1 hour 14 minutes ago CANCOM SE: Annual General Meeting approves all proposed resolutions by a large majority
Published on 06/17/2026 at 15:38, 1 hour 29 minutes ago United Terra Enterprises PLC Expands Renewable Portfolio via Strategic Alternative Energy Joint Venture Company in Ghana
Published on 06/17/2026 at 08:45, 8 hours 23 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/17/2026 at 08:45, 8 hours 23 minutes ago Air Liquide remporte son plus grand contrat jamais signé en Espagne pour prendre en charge à domicile 90 000 patients atteints de pathologies respiratoires
Published on 06/16/2026 at 18:39, 22 hours 28 minutes ago COMPTE RENDU DE L'ASSEMBLEE GENERALE ORDINAIRE ANNUELLE & EXTRAORDINAIRE DU 16 JUIN 2026
Published on 06/16/2026 at 18:00, 23 hours 8 minutes ago APPROBATION PAR L'ASSEMBLÉE GÉNÉRALE DU TRANSFERT DE LA COTATION DES TITRES GERARD PERRIER INDUSTRIE SUR EURONEXT GROWTH PARIS
Published on 06/16/2026 at 17:45, 23 hours 23 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mai 2026
